PAK1 and Alzheimer disease: Because dysregulated PAK1 activity in AD is associated with synaptic malfunction and dendritic spine loss,15 we determined whether the inhibition of PAK1 activity observed in our study mitigates spine loss induced by Aβ deposition in 5xFAD mice.